Table 1 Distribution of the study population with respect to age, gender and study site
Epidemiological strata | Study sites | Age (months) | Total | ||||
|---|---|---|---|---|---|---|---|
< 60 | 60–119 | 120+ | |||||
HWP | Bamenda | Gender | F | 70 (40.5) | 29 (16.8) | 74 (42.8) | 173 (54.4) |
M | 58 (40.0) | 38 (26.2) | 49 (33.8) | 145 (45.6) | |||
Total | 128 (40.3) | 67 (21.1) | 123 (38.7) | 318 | |||
C | Limbe | Gender | F | 75 (50.3) | 39 (26.2) | 35 (23.5) | 149 (46.9) |
M | 103 (61.0) | 39 (23.1) | 27 (15.9) | 169 (53.1) | |||
Total | 178 (56.0) | 78 (24.5) | 62 (19.5) | 318 | |||
SCEF | Yaounde | Gender | F | 61 (40.7) | 32 (21.3) | 57 (38.0) | 150 (44.0) |
M | 100 (52.4) | 46 (24.1) | 45 (23.6) | 191 (56.0) | |||
Total | 161 (47.2) | 78 (22.9) | 102 (29.9) | 341 | |||
SS | Maroua | Gender | F | 122 (74.4) | 27 (16.5) | 15 (9.1) | 164 (52.1) |
M | 111 (73.5) | 27 (17.9) | 13 (8.6) | 151 (47.9) | |||
Total | 233 (74.0) | 54 (17.1) | 28 (8.9) | 315 | |||
HIP | Ngaoundere | Gender | F | 94 (65.7) | 32 (22.4) | 17 (11.9) | 143 (45.1) |
M | 116 (66.7) | 34 (19.5) | 24 (13.8) | 174 (54.9) | |||
Total | 210 (66.3) | 66 (20.8) | 41 (12.9) | 317 | |||
Total | Gender | F | 422 (54.2) | 159 (20.4) | 198 (25.4) | 779 (48.4) | |
M | 488 (58.8) | 184 (22.2) | 158 (19.0) | 830 (51.6) | |||
Total | 910 (56.6) | 343 (21.3) | 356 (22.1) | 1609 | |||